OPKO Health, Inc. (BMV:OPK)

Market Cap	19.38B
Revenue (ttm)	11.78B
Net Income (ttm)	-3.31B
Shares Out	n/a
EPS (ttm)	-4.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76
Average Volume	4
Open	27.00
Previous Close	25.00
Day's Range	27.00 - 27.00
52-Week Range	25.00 - 38.25
Beta	1.81
RSI	99.61
Earnings Date	Oct 29, 2025

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: OPK

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD